Professor of Neurology & Group leader in the Department of Neurogenetics, Max Planck Institute (MPI) of Experimental Medicine, Göttingen, Germany
Dr. Michael Sereda M.D. is Professor of Neurology and Group leader in the Department of Neurogenetics, Max Planck Institute (MPI) of Experimental Medicine, Göttingen, Germany. He was a postdoctoral fellow in the group of Prof K.-A. Nave, PhD at MPI. He also completed a Residency in Neurology in the Dept. of Clinical Neurophysiology and Neurology, University of Göttingen and is currently Consultant Neurologist there. Hisdomain of research is Schwann cell and molecular biology as well as axon-glia interaction and disease mechanisms of Charcot-Marie-Tooth disease.
He has generated a transgenic rat model of CMT1A which is helpful in the analysis of modifier genes, epigenetic factors, and in the evaluation of experimental treatment strategies. He has also recently identified biomarkers of disease severity in CMT1A patients and is currently validating markers in patients from across Europe which should help in performing clinical trials in the near future.